This inventor holds 1 USPTO granted patent. Top assignee: Celgene Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Annette Ervin-Hayes in Lymphoma Treatment
Introduction
Annette Ervin-Hayes, an accomplished inventor based in Watchung, NJ, has made significant contributions to the field of medical therapies, particularly for lymphoma treatment. With her innovative methods, she aims to enhance patient outcomes through targeted therapies.
Latest Patents
Ervin-Hayes holds a patent for methods related to treating lymphomas in specific patient populations and for screening these patients for the therapy. Her patent details the methods for predicting a patient's response to a particular therapy regimen, known as 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione. This approach utilizes prognostic factors such as a patient's disease burden, absolute lymphocyte count, and time since the last rituximab therapy. The methods include administering the aforementioned compound to patients with favorable profiles, either alone or in conjunction with immunosuppressive agents like rituximab.
Career Highlights
Annette Ervin-Hayes is currently affiliated with Celgene Corporation, a leader in biopharmaceutical innovations. Her role involves cutting-edge research aimed at developing effective treatments for complex diseases, including lymphomas. With one patent to her name, her work exemplifies the impact an inventor can have in the medical field.
Collaborations
Throughout her career, Ervin-Hayes has collaborated with respected colleagues such as Dennis D Pietronigro and Jerome B Zeldis. These partnerships reflect her commitment to fostering innovation through teamwork and the sharing of expertise in the development of new treatment methodologies.
Conclusion
Annette Ervin-Hayes represents the essence of a dedicated inventor striving to improve patient care through innovative medical solutions. Her achievements in developing methods for lymphoma treatment underscore the importance of research and collaboration in advancing healthcare. The insights gained from her work will undoubtedly inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile